M. Cengiz Et Al. , "CDKN2A and CDKN2BAS expression levels in patients with atherosclerosis," 38th Congress of the Federation-of-European-Biochemical-Societies (FEBS) , vol.280, Saint Peter, Guernsey And Alderney, pp.350, 2013
Cengiz, M. Et Al. 2013. CDKN2A and CDKN2BAS expression levels in patients with atherosclerosis. 38th Congress of the Federation-of-European-Biochemical-Societies (FEBS) , (Saint Peter, Guernsey And Alderney), 350.
Cengiz, M., Arslan, C., Gode, S., Dagistanli, F. K., Arapi, B., Deser, S. B., ... Bayoglu, B.(2013). CDKN2A and CDKN2BAS expression levels in patients with atherosclerosis . 38th Congress of the Federation-of-European-Biochemical-Societies (FEBS) (pp.350). Saint Peter, Guernsey And Alderney
Cengiz, M. Et Al. "CDKN2A and CDKN2BAS expression levels in patients with atherosclerosis," 38th Congress of the Federation-of-European-Biochemical-Societies (FEBS), Saint Peter, Guernsey And Alderney, 2013
Cengiz, M. Et Al. "CDKN2A and CDKN2BAS expression levels in patients with atherosclerosis." 38th Congress of the Federation-of-European-Biochemical-Societies (FEBS) , Saint Peter, Guernsey And Alderney, pp.350, 2013
Cengiz, M. Et Al. (2013) . "CDKN2A and CDKN2BAS expression levels in patients with atherosclerosis." 38th Congress of the Federation-of-European-Biochemical-Societies (FEBS) , Saint Peter, Guernsey And Alderney, p.350.
@conferencepaper{conferencepaper, author={M. Cengiz Et Al. }, title={CDKN2A and CDKN2BAS expression levels in patients with atherosclerosis}, congress name={38th Congress of the Federation-of-European-Biochemical-Societies (FEBS)}, city={Saint Peter}, country={Guernsey And Alderney}, year={2013}, pages={350} }